Abstract:Background: Glutamate (Glu) is essential to central nervous system function; however excessive Glu release leads to neurodegenerative disease. Strategies to protect neurons are underdeveloped, in part due to a limited understanding of natural neuroprotective mechanisms, such as those present in the suprachiasmatic nucleus (SCN). This study tests the hypothesis that activation of ERK/MAPK provides essential protection to the SCN after exposure to excessive Glu using the SCN2.2 cells as a model. Methodology: Immortalized SCN2.2 cells (derived from SCN) and GT1-7 cells (neurons from the neighboring hypothalamus) were treated with 10 mM Glu in the presence or absence of the ERK/MAPK inhibitor PD98059. Cell death was assessed by Live/Dead assay, MTS assay and TUNEL. Caspase 3 activity was also measured. Activation of MAPK family members was determined by immunoblot. Bcl2, neuritin and Bid mRNA (by quantitative-PCR) and protein levels (by immunoblot) were also measured. Principal findings: As expected Glu treatment increased caspase 3 activity and cell death in the GT1-7 cells, but Glu alone did not induce cell death or affect caspase 3 activity in the SCN2.2 cells. However, pretreatment with PD98059 increased caspase 3 activity and resulted in cell death after Glu treatment in SCN2.2 cells. This effect was dependent on NMDA receptor activation. Glu treatment in the SCN2.2 cells resulted in sustained activation of the anti-apoptotic pERK/MAPK, without affecting the pro-apoptotic p-p38/MAPK. In contrast, Glu exposure in GT1-7 cells caused an increase in p-p38/MAPK and a decrease in pERK/MAPK. Bcl2-protein increased in SCN2.2 cells following Glu treatment, but not in GT1-7 cells; bid mRNA and cleaved-Bid protein increased in GT1-7, but not SCN2.2 cells. Conclusions: Facilitation of ERK activation and inhibition of caspase activation promotes resistance to Glu excitotoxicity in SCN2.2 cells. Significance: Further research will explore ERK/MAPK as a key molecule in the prevention of neurodegenerative processes.

The role of CaMKII in BDNF-mediated neuroprotection of retinal ganglion cells (RGC-5).

Retinal ganglion cell death and neuroprotection: Involvement of the CaMKIIα gene

Camkii Alpha B Mediates A Survival Response In Retinal Ganglion Cells Subjected To A Glutamate Stimulus

Glutamate-Induced Nf Kappa B Activation In The Retina

Ca2+/Calmodulin-Dependent Protein Kinase II Enhances Retinal Ganglion Cell Survival But Suppresses Axon Regeneration after Optic Nerve Injury

NMDA receptor activation modulates programmed cell death during early post-natal retinal development: a BDNF-dependent mechanism

Brain-Derived Neurotrophic Factor Activation Of Cam-Kinase Kinase Via Transient Receptor Potential Canonical Channels Induces The Translation And Synaptic Incorporation Of Glua1-Containing Calcium-Permeable Ampa Receptors

BDNF regulates GLAST and glutamine synthetase in mouse retinal Müller cells.

Preservation of vision after CaMKII-mediated protection of retinal ganglion cells

The release of glutamate from cortical neurons regulated by BDNF via the TrkB/Src/PLC-γ1 pathway.

Casein kinase-II inhibition promotes retinal ganglion cell survival and axonal regeneration.

ERK/MAPK is essential for endogenous neuroprotection in SCN2.2 cells

Involvement of Calpain/p35-P25/cdk5/nmdar Signaling Pathway in Glutamate-Induced Neurotoxicity in Cultured Rat Retinal Neurons.

Neuroprotective effect of gene transfection of cyclic adenosine monophosphate response element binding protein on primary murine retinal ganglion cells

Pin1 is Regulated by CaMKII Activation in Glutamate-Induced Retinal Neuronal Regulated Necrosis

CaMKII-Mediated CREB Phosphorylation is Involved in Ca2+-Induced BDNF Mrna Transcription and Neurite Outgrowth Promoted by Electrical Stimulation

CD3ζ-Mediated Signaling Protects Retinal Ganglion Cells in Glutamate Excitotoxicity of the Retina

Brain-derived neurotrophic factor uses CREB and Egr3 to regulate NMDA receptor levels in cortical neurons

Active Calcium/Calmodulin-Dependent Protein Kinase II (camkii) Regulates NMDA Receptor Mediated Postischemic Long-Term Potentiation (I-Ltp) by Promoting the Interaction Between CaMKII and NMDA Receptors in Ischemia

Camkii Phosphorylates Collapsin Response Mediator Protein 2 and Modulates Axonal Damage During Glutamate Excitotoxicity

An Agonistic Trkb Mab Causes Sustained Trkb Activation, Delays Rgc Death, And Protects The Retinal Structure In Optic Nerve Axotomy And In Glaucoma